In Vitro ADME検査サービスの世界市場規模：タイプ別、用途別、地域別、範囲および予測

In Vitro ADME検査サービスの市場規模と予測

In Vitro ADME検査サービスの市場規模は、2024年に63億1,000万米ドルと評価され、2024年から2031年にかけてCAGR 9.29%で成長し、2031年には128億5,000万米ドルに達すると予測されています。市場の開拓は、いくつかの疾患に対する新薬開発のための研究努力の増加によって支援されています。この調査レポートは、世界のIn Vitro ADME検査サービス市場を総合的に評価したものです。主要セグメント、動向、市場促進要因、競合情勢、市場で重要な役割を果たしている要因などを包括的に分析しています。

世界のIn Vitro ADME検査サービス市場の定義

ADMEとは、人体における物質や薬剤の吸収、分布、代謝、排泄を意味する略語で、薬物動態学や薬理学で用いられます。さらに、化合物候補の有効性と安全性プロファイルに影響を与える主な物理化学的特徴と構造モチーフを理解することは、医薬品研究の初期段階において非常に重要です。In vitroでは、ADMEは吸収、分布、代謝、排泄の特性を決定するために用いられます。ADME試験は、代謝および可能性のある薬物相互作用を理解するために不可欠です。

さらに、試験管内感染では、薬物動態モデルは研究者が抗菌薬の薬力学的特徴をよりよく理解するのに役立ちます。動物やヒトの薬力学的試験と併用することで、投薬レジメンの最適化に役立つデータが得られます。In vitroモデルは、細菌集団に対する薬剤の効果を特徴付けるため、あるいは仮説検証などのより分析的な研究のためのデータを得るために使用することができます。分析的試験デザインは、望ましい結果に最も密接に関連する薬力学的パラメータとその大きさを明らかにします。

世界のIn Vitro ADME検査サービス市場概要

In Vitro ADME検査サービスの世界市場は、医薬品開発研究への資金開拓が活発化しているなどの要因から成長しています。市場の拡大は、いくつかの病気に対する新薬を開発するための研究努力の増加によって助けられています。また、慢性疾患、感染症、遺伝性疾患の数が増加するにつれて、効果的な治療法のニーズも高まり、ADME試験サービスの利用が促進されています。

さらに、動物を使用するのに比べ培養による製造は簡便であるため、in vitro法は製薬部門による大規模製造に頻繁に選択される方法となっています。In vitro ADME試験サービスの世界市場の成長を阻害する要因としては、マウス腹水法ではマウスを使用する必要があり、定期的に観察する必要があること、In vivo MAbではさまざまなマウスタンパク質やその他の汚染物質が含まれる可能性があり、精製が必要になる場合があることなどが挙げられます。

目次

第1章 In Vitro ADME検査サービスの世界市場：イントロダクション

• 市場概要
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• バリデーション
• 一次インタビュー
• データソース一覧

第4章 In Vitro ADME検査サービスの世界市場展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析

第5章 In Vitro ADME検査サービスの世界市場：タイプ別

• 概要
• 低分子
• 生物製剤

第6章 In Vitro ADME検査サービスの世界市場：用途別

• 概要
• 血漿タンパク質結合
• 血液／血漿比
• 代謝安定性
• シトクロム酵素誘導／阻害

第7章 In Vitro ADME検査サービスの世界市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋地域
• 世界のその他の地域
  • ラテンアメリカ
  • 中東・アフリカ

第8章 In Vitro ADME検査サービスの世界市場：競合情勢

• 概要
• 企業の市場ランキング
• 主な発展戦略

第9章 企業プロファイル

• Pharmaceutical Product Development
• Pharmaron
• Albany Molecular Research
• Charles River Laboratories
• Galapagos
• EnvisionTEC
• Tecan Group

第10章 付録

• 関連調査

In Vitro ADME Testing Services Market Size And Forecast

In Vitro ADME Testing Services Market size was valued at USD 6.31 Billion in 2024 and is projected to reach USD 12.85 Billion by 2031, growing at a CAGR of 9.29% from 2024 to 2031. The market's expansion is being aided by increased research endeavors to develop novel drugs for several illnesses. The Global In Vitro ADME Testing Services Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global In Vitro ADME Testing Services Market Definition

The abbreviation ADME, which stands for absorption, distribution, metabolism, and elimination of substances and medications in the human body, is used in pharmacokinetics and pharmacology. Furthermore, Understanding the main physicochemical features and structural motifs that influence a compound candidate's effectiveness and safety profile is critical in the early phases of drug research. In vitro, ADME is used to determine absorption, distribution, metabolism, and excretion characteristics. ADME tests are essential for understanding metabolism and possible medication interactions.

Additionally, In vitro infection, pharmacokinetic models can help researchers better understand the pharmacodynamic features of antibacterial drugs. They give data to assist in the optimization of medication dosage regimens when used in conjunction with animal and human pharmacodynamic studies. In vitro models can be used to characterize a drug's effect on a bacterial population or to give data for more analytical research, such as hypothesis testing. Analytical study designs reveal the pharmacodynamic parameter that is most closely linked to the desired outcome, as well as its magnitude.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global In Vitro ADME Testing Services Market Overview

Global In Vitro ADME Testing Services Market is growing because of some factors such as Funding for drug development research has been boosted. The market's expansion is being aided by increased research endeavors to develop novel drugs for several illnesses. In addition, as the number of chronic, infectious, and hereditary disorders rises, so does the need for effective treatments, which promotes the use of ADME Testing services.

Moreover, Because of the simplicity of culture for production compared to the use of animals, in vitro methods are frequently the methods of choice for large-scale manufacturing by the pharmaceutical sector. Some factors hampering the growth of the Global In Vitro ADME Testing Services Market are the mouse ascites approach necessitates the use of mice that must be observed regularly, and In vivo MAb can include a variety of mouse proteins and other pollutants, which may necessitate purification.

Global In Vitro ADME Testing Services Market Segmentation Analysis

The Global In Vitro ADME Testing Services Market is Segmented on the basis of Type, Application, And Geography.

In Vitro ADME Testing Services Market, By Type

• Small Molecules
• Biologics

Based on the Type, the market is into Small Molecules and Biologics. Small molecules are majorly helpful to the growth of the market because small compounds offer various benefits over biologics. Small molecules, on the other hand, are more likely to cause harmful non-target effects because biologics are very target-specific and their side effects are mostly related to exaggerated pharmacological effects, whereas biologics are very target-specific and their side effects are mostly related to exaggerated pharmacological effects.

In Vitro ADME Testing Services Market, By Application

• Plasma Protein Binding
• Blood to Plasma Ratio
• Metabolic Stability
• Cytochrome Enzyme Induction / Inhibition
• Based on Application, the market is segmented into Plasma Protein Binding, Blood to Plasma Ratio, Metabolic Stability, and Cytochrome Enzyme Induction / Inhibition. Plasma protein binding stakes a major share in the expansion of global In vitro ADME testing services owing to plasma protein bindings are used to measure the potency of a drug which is a very important parameter,

In Vitro ADME Testing Services Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world
• On the basis of Geography, the Global In Vitro ADME Testing Services Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America is anticipated to dominate the Global In Vitro ADME Testing Services Market due to the rapid adoption of newer technologies, and the presence of government rules and regulations which benefits able to the growth of the market.

Key Players

• The "Global In Vitro ADME Testing Services Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
• Pharmaceutical Product Development, Pharmaron, Albany Molecular Research, Charles River Laboratories, Galapagos, EnvisionTEC, and Tecan Group.

Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

Key Developments

• In December 2021, Color Health, a health technology business dedicated to enhancing public health, and Thermo Fisher Scientific, a world leader in serving research, announced a substantial extension of their partnership. In Texas, the ReadyCheckGo COVID-19 testing system is used in K-12 schools.
• In February 2020, Catalent, Inc. ("Catalent"), the world's leading provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced that Catalent Pharma Solutions, Inc., a wholly-owned subsidiary of Catalent, Inc.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL IN VITRO ADME TESTING SERVICES MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL IN VITRO ADME TESTING SERVICES MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL IN VITRO ADME TESTING SERVICES MARKET, BY TYPE

• 5.1 Overview
• 5.2 Small Molecules
• 5.3 Biologics

6 GLOBAL IN VITRO ADME TESTING SERVICES MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Plasma Protein Binding
• 6.3 Blood to Plasma Ratio
• 6.4 Metabolic Stability
• 6.5 Cytochrome Enzyme Induction / Inhibition

7 GLOBAL IN VITRO ADME TESTING SERVICES MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East & Africa

8 GLOBAL IN VITRO ADME TESTING SERVICES MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Pharmaceutical Product Development
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 Pharmaron
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Albany Molecular Research
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Charles River Laboratories
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 Galapagos
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 EnvisionTEC
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 Tecan Group
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments

10 Appendix

• 10.1 Related Research